Home › Analysts Start to Turn Against Valeant After Worst Day Ever
 

Keywords :   


Analysts Start to Turn Against Valeant After Worst Day Ever

2016-03-18 00:30:03| Biotech - Topix.net

One of Valeant Pharmaceuticals International Inc.'s biggest sell-side supporters downgraded her rating on the company's stock Wednesday, following other analysts who are starting to turn against the drugmaker after a 51 percent drop in the shares Tuesday. Shibani Malhotra, an analyst with Nomura Securities, cut her rating on the shares to neutral and gave a $60 12-month price target.

Tags: day start ever turn

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
09.05Skin Care Composition Prevents and Treats Pollution Damage
09.05Demand, crop prospects, global geopolitics: What's ahead?
09.05Scalstrm and EZDRM partner on video content security
09.05Appvion launches EarthChem sustainable direct thermal portfolio
09.05Glatfelter Reports Financial Results
09.05Maryland Adopts PaintCare Program
09.05Society of Cosmetic Chemists Intermountain West to Host Healthy Bite Oral Care Symposium
09.05A.Celli and Akinal Tekstil Collaborate on Line Installation
More »